Beyond corticosteroids: future prospects in the management of inflammation in COPD
Inflammation plays a central role in the pathophysiology of chronic obstructive pulmonary disease (COPD). Exposure to cigarette smoke induces the recruitment of inflammatory cells in the airways and stimulates innate and adaptive immune mechanisms. Airway inflammation is involved in increased bronch...
Main Authors: | N. Roche, R. Marthan, P. Berger, A. Chambellan, P. Chanez, B. Aguilaniu, P-Y Brillet, P-R Burgel, A. Chaouat, P. Devillier, R. Escamilla, R. Louis, H. Mal, J-F Muir, T. Pérez, T. Similowski, B. Wallaert, M. Aubier |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2011-09-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/content/20/121/175.full.pdf+html |
Similar Items
-
Revisited role for mucus hypersecretion in the pathogenesis of COPD
by: I. Cerveri, et al.
Published: (2010-06-01) -
Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
by: Martin C, et al.
Published: (2021-08-01) -
Stigmasterol alleviates allergic airway inflammation and airway hyperresponsiveness in asthma mice through inhibiting substance-P receptor
by: Jimei Zhang, et al.
Published: (2023-12-01) -
MicroRNAs Associated with Chronic Mucus Hypersecretion in COPD Are Involved in Fibroblast–Epithelium Crosstalk
by: Hataitip Tasena, et al.
Published: (2022-02-01) -
Emerging pharmaceutical therapies for COPD
by: Lakshmi SP, et al.
Published: (2017-07-01)